Maraviroc-Based GVHD Prophylaxis in HLA-Unrelated and HLA-Mismatched Related Transplantation

NCT02799888 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Graft-versus-host Disease
Hematopoietic Stem Cell Transplantation

Interventions

DRUG: Maraviroc
DRUG: Cyclosporine (in HLA-Unrelated Donor Transplantation)
DRUG: Tacrolimus (in HLA-Mismatched Related Donor Transplantation)
DRUG: Methotrexate

Sponsor

Affiliated Hospital to Academy of Military Medical Sciences